Home General Biotechnology Drug Patent Expirations in November 2013

Drug Patent Expirations in November 2013

Drug Patent Expirations for November 2013

TradenameApplicantGeneric NamePatent NumberPatent Expiration
SAMSCAOtsuka America Pharmtolvaptan5,258,510Nov 2, 2013
PROPECIAMerckfinasteride5,571,817Nov 5, 2013
ACIPHEX SPRINKLEEisai Incrabeprazole sodium5,045,552*PEDNov 8, 2013
ACIPHEXEisai Incrabeprazole sodium5,045,552*PEDNov 8, 2013
TECHNESCAN MAG3Mallinckrodttechnetium tc-99m mertiatide kit5,573,748Nov 12, 2013
EXPARELPacira Pharms Incbupivacaine6,132,766Nov 16, 2013
SURFAXINDiscovery Labslucinactant5,407,914Nov 17, 2013
SUSTIVABristol Myers Squibbefavirenz5,519,021*PEDNov 21, 2013
ATRIPLAGileadefavirenz; emtricitabine; tenofovir disoproxil fumarate5,519,021*PEDNov 21, 2013
JEVTANA KITSanofi Aventis Uscabazitaxel5,438,072Nov 22, 2013
CHILDREN'S ALLEGRA ALLERGYSanofi Aventis Usfexofenadine hydrochloride5,578,610Nov 26, 2013
ALINIARomarknitazoxanide5,578,621Nov 26, 2013
CHILDREN'S ALLEGRA HIVESSanofi Aventis Usfexofenadine hydrochloride5,578,610Nov 26, 2013
ALLEGRASanofi Aventis Usfexofenadine hydrochloride5,578,610Nov 26, 2013
ZOLINZAMerckvorinostatRE38506Nov 29, 2013
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.
Contact Us with any questions.